NIKKEI 225
39,869.33 +238.27 (+0.60%) HANG SENG
17,823.85 +105.24 (+0.59%) CRUDE OIL
83.51 +0.13 (+0.16%) GOLD FUTURES
2,342.20 +3.30 (+0.14%) DOW
39,169.52 +50.66 (+0.13%) Bitcoin GBP
49,723.89 -509.70 (-1.01%)
Daré Bioscience, Inc. (DARE)
After hours:
- GlobeNewswire
Daré Bioscience Announces Reverse Stock Split
Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024 SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced that it will implement a 1-for-12 reverse split of the issued shares of its common stock, effective at 12:01 a.m. Eastern Time on July 1, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on Monday, July 1,
- GlobeNewswire
Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder
Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with or without concomitant decreased desire There are currently no FDA-approved therapies for FSAD SAN DIEGO, June 24, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced the publication in Obstetrics & Gynecology, the o
- Thomson Reuters StreetEvents
Q1 2024 Dare Bioscience Inc Earnings Call
Q1 2024 Dare Bioscience Inc Earnings Call
